Simvastatin and Daptomycin Interaction

Drug interaction information between Simvastatin and Daptomycin.

Simvastatin and Daptomycin have a documented moderate interaction in FDA labeling.

FDA drug labeling documents a moderate-severity interaction between Simvastatin and Daptomycin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Simvastatin

HMG-CoA Reductase Inhibitor (Statin)

Drug B

Daptomycin

Lipopeptide Antibiotic

How They Interact

Both drugs can cause muscle damage on their own, so taking them together increases the risk of severe muscle breakdown.

FDA Label Information

Daptomycin Clinical Impact: Cases of rhabdomyolysis have been reported with simvastatin administered with daptomycin. Both ezetimibe and simvastatin and daptomycin can cause myopathy and rhabdomyolysis when given alone and the risk of myopathy and rhabdomyolysis may be increased by coadministration. Intervention: If treatment with daptomycin is required, consider temporarily suspending ezetimibe and simvastatin during the course of daptomycin treatment.

Frequently Asked Questions

What SPL severity band is on file for Simvastatin + Daptomycin?

Compiled FDA labeling labels this pair moderate. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Simvastatin has 41 labeled pairs on file vs Daptomycin's 3. In the moderate band specifically: Simvastatin has 9 (also Ezetimibe, Colchicine, Niacin, Bempedoic Acid); Daptomycin has 3 (also Ezetimibe, Ezetimibe/Simvastatin).

What mechanism field is on file for Simvastatin and Daptomycin?

Both drugs can cause muscle damage on their own, so taking them together increases the risk of severe muscle breakdown.

Simvastatin carries more major-labeled pairs than Daptomycin

SPL source-record counts only. This page's band is moderate · classes on file: Simvastatin (HMG-CoA Reductase Inhibitor (Statin)); Daptomycin (Lipopeptide Antibiotic).

Simvastatin has 11 major-labeled pairs vs Daptomycin's 0. This page itself is in the moderate band, not the major band.

Simvastatin

11 major · 9 moderate · 21 minor · 41 total

Daptomycin

0 major · 3 moderate · 0 minor · 3 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.